JAMDA
February 3, 2024
Showing 861 - 870 of 2684 results
February 3, 2024
This program explores the prevalence, impact, and symptoms of agitation associated with dementia due to Alzheimer’s disease, specifically focusing on patients living in a long-term care setting. Participants will review the current clinical care landscape for treatment of agitation associated with dementia due to Alzheimer's disease. The program will also provide an overview of the Centers for Medicare & Medicaid Services Regulations on Antipsychotics.
Read MoreFebruary 21, 2018
December 27, 2022
February 25, 2020
February 25, 2020
July 2, 2015
February 7, 2014
February 7, 2014
June 2, 2015